相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Eliminating minimal residual disease as a therapeutic end point: working toward cure for patients with CLL
Philip A. Thompson et al.
BLOOD (2016)
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies
Harriet S. Walter et al.
BLOOD (2016)
Fludarabine, cyclophosphamide, and rituximab treatment achieves long-term disease-free survival in IGHV-mutated chronic lymphocytic leukemia
Philip A. Thompson et al.
BLOOD (2016)
Long-term remissions after FCR chemoimmunotherapy in previously untreated patients with CLL: updated results of the CLL8 trial
Kirsten Fischer et al.
BLOOD (2016)
Whole-exome sequencing in relapsing chronic lymphocytic leukemia: clinical impact of recurrent RPS15 mutations
Viktor Ljungstrom et al.
BLOOD (2016)
Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib - Findings from an Investigator-Initiated Phase II Study
Carsten U. Niemann et al.
CLINICAL CANCER RESEARCH (2016)
Wnt5a induces ROR1/ROR2 heterooligomerization to enhance leukemia chemotaxis and proliferation
Jian Yu et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Outcomes for patients with chronic lymphocytic leukemia and acute leukemia or myelodysplastic syndrome
F. P. Tambaro et al.
LEUKEMIA (2016)
P-048Prognostic Impact of CA19-9 Level at Diagnosis in Resected Stage I-III Pancreatic Adenocarcinoma: a US Population Study
K. Mirkin et al.
ANNALS OF ONCOLOGY (2016)
IL-4 enhances expression and function of surface IgM in CLL cells
Maria M. Aguilar-Hernandez et al.
BLOOD (2016)
High-level ROR1 associates with accelerated disease progression in chronic lymphocytic leukemia
Bing Cui et al.
BLOOD (2016)
Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity
Benjamin L. Lampson et al.
BLOOD (2016)
Ibrutinib enhances chimeric antigen receptor T-cell engraftment and efficacy in leukemia
Joseph A. Fraietta et al.
BLOOD (2016)
The Dohner fluorescence insitu hybridization prognostic classification of chronic lymphocytic leukaemia (CLL): the CLL Research Consortium experience
Daniel L. Van Dyke et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
A high rate of telomeric sister chromatid exchange occurs in chronic lymphocytic leukaemia B-cells
Sandrine Medves et al.
BRITISH JOURNAL OF HAEMATOLOGY (2016)
Genetic Variation Associated with Longer Telomere Length Increases Risk of Chronic Lymphocytic Leukemia
Juhi Ojha et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2016)
Ofatumumab and Lenalidomide for Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia: Correlation between Responses and Immune Characteristics
Candida Vitale et al.
CLINICAL CANCER RESEARCH (2016)
Intravenous versus subcutaneous immunoglobulin replacement in secondary hypogammaglobulinemia
Giuseppe Spadaro et al.
CLINICAL IMMUNOLOGY (2016)
Prognostic impact of epigenetic classification in chronic lymphocytic leukemia: The case of subset #2
Sujata Bhoi et al.
EPIGENETICS (2016)
Combination of bendamustine and rituximab as frontline therapy for patients with chronic lymphocytic leukaemia: multicenter, retrospective clinical practice experience with 279 cases outside of controlled clinical trials
Massimo Gentile et al.
EUROPEAN JOURNAL OF CANCER (2016)
Continuous inhibitory signaling by both SHP-1 and SHIP-1 pathways is required to maintain unresponsiveness of anergic B cells
Andrew Getahun et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2016)
Second-generation inhibitors of Bruton tyrosine kinase
Jingjing Wu et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2016)
An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data
Michael Hallek
LANCET ONCOLOGY (2016)
First-line chemoimmunotherapy with bendamustine and rituximab versus fludarabine, cyclophosphamide, and rituximab in patients with advanced chronic lymphocytic leukaemia (CLL10): an international, open-label, randomised, phase 3, non-inferiority trial
Barbara Eichhorst et al.
LANCET ONCOLOGY (2016)
Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study
Stephan Stilgenbauer et al.
LANCET ONCOLOGY (2016)
Effect of first-line treatment on second primary malignancies and Richter's transformation in patients with CLL
C. Maurer et al.
LEUKEMIA (2016)
Results of a phase II study of lenalidomide and rituximab for refractory/relapsed chronic lymphocytic leukemia
Julio C. Chavez et al.
LEUKEMIA RESEARCH (2016)
Ionizing radiation exposures in treatments of solid neoplasms are not associated with subsequent increased risks of chronic lymphocytic leukemia
Tomas Radivoyevitch et al.
LEUKEMIA RESEARCH (2016)
DNA methylation dynamics during B cell maturation underlie a continuum of disease phenotypes in chronic lymphocytic leukemia
Christopher C. Oakes et al.
NATURE GENETICS (2016)
Driving CAR T-cells forward
Hollie J. Jackson et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
Targeting BCL2 with Venetoclax in Relapsed Chronic Lymphocytic Leukemia
Andrew W. Roberts et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
John C. Byrd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Epstein-Barr virus-positive diffuse large B cell lymphoma arising from a chronic lymphocytic leukemia: Overlapping features with classical Hodgkin lymphoma
Yun-An Chen et al.
PATHOLOGY INTERNATIONAL (2016)
Richter syndrome: pathogenesis and management
Davide Rossi et al.
SEMINARS IN ONCOLOGY (2016)
Clonal evolution in patients with chronic lymphocytic leukaemia developing resistance to BTK inhibition
Jan A. Burger et al.
NATURE COMMUNICATIONS (2016)
Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia
Sonja I. Berndt et al.
NATURE COMMUNICATIONS (2016)
Rituximab maintenance versus observation alone in patients with chronic lymphocytic leukaemia who respond to first-line or second-line rituximab-containing chemoimmunotherapy: final results of the AGMT CLL-8a Mabtenance randomised trial
Richard Greil et al.
LANCET HAEMATOLOGY (2016)
Insecticide exposure and farm history in relation to risk of lymphomas and leukemias in the Women's Health Initiative observational study cohort
Leah H. Schinasi et al.
ANNALS OF EPIDEMIOLOGY (2015)
Chronic lymphocytic leukaemia: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upaEuro
B. Eichhorst et al.
ANNALS OF ONCOLOGY (2015)
No evidence of transmission of chronic lymphocytic leukemia through blood transfusion
Henrik Hjalgrim et al.
BLOOD (2015)
Obinutuzumab plus fludarabine/cyclophosphamide or bendamustine in the initial therapy of CLL patients: the phase 1b GALTON trial
Jennifer R. Brown et al.
BLOOD (2015)
PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia
Fabienne McClanahan et al.
BLOOD (2015)
Familial predisposition and genetic risk factors for lymphoma
James R. Cerhan et al.
BLOOD (2015)
Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL
Romain Guieze et al.
BLOOD (2015)
Perturbation of the normal immune system in patients with CLL
Francesco Forconi et al.
BLOOD (2015)
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia
Davide Rossi et al.
BLOOD (2015)
Monoclonal B-cell lymphocytosis and early-stage chronic lymphocytic leukemia: diagnosis, natural history, and risk stratification
Paolo Strati et al.
BLOOD (2015)
Mycophenolate mofetil therapy for severe immune thrombocytopenia
Alice Taylor et al.
BRITISH JOURNAL OF HAEMATOLOGY (2015)
Complex Karyotype is a Stronger Predictor Than Del(17p) for an Inferior Outcome in Relapsed or Refractory Chronic Lymphocytic Leukemia Patients Treated With Ibrutinib-Based Regimens
Philip A. Thompson et al.
CANCER (2015)
Racial differences in three major NHL subtypes: Descriptive epidemiology
Yang Li et al.
CANCER EPIDEMIOLOGY (2015)
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
Padmanee Sharma et al.
CELL (2015)
Pharmacological and Protein Profiling Suggests Venetoclax (ABT-199) as Optimal Partner with Ibrutinib in Chronic Lymphocytic Leukemia
Fabiola Cervantes-Gomez et al.
CLINICAL CANCER RESEARCH (2015)
Survival for patients with chronic leukemias in the US and Britain: Age-related disparities and changes in the early 21st century
Dianne Pulte et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2015)
Chlorambucil plus ofatumumab versus chlorambucil alone in previously untreated patients with chronic lymphocytic leukaemia (COMPLEMENT 1): a randomised, multicentre, open-label phase 3 trial
Peter Hillmen et al.
LANCET (2015)
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease
F. R. Mauro et al.
LEUKEMIA (2015)
Management of adverse events associated with idelalisib treatment: expert panel opinion
Steven E. Coutre et al.
LEUKEMIA & LYMPHOMA (2015)
Lenalidomide induces ubiquitination and degradation of CK1a in del(5q) MDS
Jan Kroenke et al.
NATURE (2015)
Non-coding recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2015)
Mutations driving CLL and their evolution in progression and relapse
Dan A. Landau et al.
NATURE (2015)
Ibrutinib as Initial Therapy for Patients with Chronic Lymphocytic Leukemia
J. A. Burger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Sleeping Beauty Transposition of Chimeric Antigen Receptors Targeting Receptor Tyrosine Kinase-Like Orphan Receptor-1 (ROR1) into Diverse Memory T-Cell Populations
Drew C. Deniger et al.
PLOS ONE (2015)
TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia
Veronica Balatti et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia
David L. Porter et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
Notch signaling sustains the expression of Mcl-1 and the activity of eIF4E to promote cell survival in CLL
Filomena De Falco et al.
Oncotarget (2015)
Allele-specific loss and transcription of the miR-15a/16-1 cluster in chronic lymphocytic leukemia
A. Veronese et al.
LEUKEMIA (2015)
The impact of SF3B1 mutations in CLL on the DNA-damage response
G. D. te Raa et al.
LEUKEMIA (2015)
A B-cell epigenetic signature defines three biologic subgroups of chronic lymphocytic leukemia with clinical impact
A. C. Queiros et al.
LEUKEMIA (2015)
Germinal centres and B cell lymphomagenesis
Katia Basso et al.
NATURE REVIEWS IMMUNOLOGY (2015)
Autoimmune cytopenias in chronic lymphocytic leukemia
Carlo Visco et al.
AMERICAN JOURNAL OF HEMATOLOGY (2014)
MicroRNA-155 influences B-cell receptor signaling and associates with aggressive disease in chronic lymphocytic leukemia
Bing Cui et al.
BLOOD (2014)
Somatic mutation as a mechanism of Wnt/β-catenin pathway activation in CLL
Lili Wang et al.
BLOOD (2014)
Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia
Natali Pflug et al.
BLOOD (2014)
Lenalidomide inhibits the proliferation of CLL cells via a cereblon/p21WAF1/Cip1-dependent mechanism independent of functional p53
Jessie-F. Fecteau et al.
BLOOD (2014)
Locally Disordered Methylation Forms the Basis of Intratumor Methylome Variation in Chronic Lymphocytic Leukemia
Dan A. Landau et al.
CANCER CELL (2014)
New Strategies in Chronic Lymphocytic Leukemia: Shifting Treatment Paradigms
Farrukh T. Awan et al.
CLINICAL CANCER RESEARCH (2014)
Prophylaxis against hepatitis B reactivation among patients with lymphoma receiving rituximab
Joseph Adrian Lumawig Buensalido et al.
EXPERT REVIEW OF ANTI-INFECTIVE THERAPY (2014)
Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia
Pedro G. Ferreira et al.
GENOME RESEARCH (2014)
The outcome of B-cell receptor signaling in chronic lymphocytic leukemia: proliferation or anergy
Graham Packham et al.
HAEMATOLOGICA (2014)
Antibody Deficiency Secondary to Chronic Lymphocytic Leukemia: Should Patients be Treated with Prophylactic Replacement Immunoglobulin?
Fatima Dhalla et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2014)
Lenalidomide and Rituximab for the Initial Treatment of Patients With Chronic Lymphocytic Leukemia: A Multicenter Clinical-Translational Study From the Chronic Lymphocytic Leukemia Research Consortium
Danelle F. James et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
CD49d Is the Strongest Flow Cytometry-Based Predictor of Overall Survival in Chronic Lymphocytic Leukemia
Pietro Bulian et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
The impact of Agent Orange exposure on presentation and prognosis of patients with chronic lymphocytic leukemia
Lisa M. Baumann Kreuziger et al.
LEUKEMIA & LYMPHOMA (2014)
Cell of origin associated classification of B-cell malignancies by gene signatures of the normal B-cell hierarchy
Hans Erik Johnsen et al.
LEUKEMIA & LYMPHOMA (2014)
The impact of race, ethnicity, age and sex on clinical outcome in chronic lymphocytic leukemia: a comprehensive Surveillance, Epidemiology, and End Results analysis in the modern era
Chadi Nabhan et al.
LEUKEMIA & LYMPHOMA (2014)
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia
Helen E. Speedy et al.
NATURE GENETICS (2014)
Resistance Mechanisms for the Bruton's Tyrosine Kinase Inhibitor Ibrutinib
Jennifer A. Woyach et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions
Valentin Goede et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
J. C. Byrd et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Idelalisib and Rituximab in Relapsed Chronic Lymphocytic Leukemia
Richard R. Furman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Evolution of DNA Methylation Is Linked to Genetic Aberrations in Chronic Lymphocytic Leukemia
Christopher C. Oakes et al.
CANCER DISCOVERY (2014)
Acquired Initiating Mutations in Early Hematopoietic Cells of CLL Patients
Frederik Damm et al.
CANCER DISCOVERY (2014)
Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia
Davide Rossi et al.
BLOOD (2013)
Identification in CLL of circulating intraclonal subgroups with varying B-cell receptor expression and function
Vania Coelho et al.
BLOOD (2013)
Two main genetic pathways lead to the transformation of chronic lymphocytic leukemia to Richter syndrome
Ekaterina Chigrinova et al.
BLOOD (2013)
TP53, SF3B1, and NOTCH1 mutations and outcome of allotransplantation for chronic lymphocytic leukemia: six-year follow-up of the GCLLSG CLL3X trial
Peter Dreger et al.
BLOOD (2013)
Receptor Affinity and Extracellular Domain Modifications Affect Tumor Recognition by ROR1-Specific Chimeric Antigen Receptor T Cells
Michael Hudecek et al.
CLINICAL CANCER RESEARCH (2013)
Phase II Study of Lenalidomide and Rituximab As Salvage Therapy for Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
Xavier C. Badoux et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome
Giulia Fabbri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments
N. Cahill et al.
LEUKEMIA (2013)
NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome
N. Villamor et al.
LEUKEMIA (2013)
Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function
DJ DiLillo et al.
LEUKEMIA (2013)
MicroRNAs and B cell receptor signaling in chronic lymphocytic leukemia
Marek Mraz et al.
LEUKEMIA & LYMPHOMA (2013)
Fludarabine: A review of the clear benefits and potential harms
Joshua Lukenbill et al.
LEUKEMIA RESEARCH (2013)
Charting a dynamic DNA methylation landscape of the human genome
Michael J. Ziller et al.
NATURE (2013)
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia
Sonja I. Berndt et al.
NATURE GENETICS (2013)
ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
Andrew J. Souers et al.
NATURE MEDICINE (2013)
The Incidence of Leukemia, Lymphoma and Multiple Myeloma among Atomic Bomb Survivors: 1950-2001
Wan-Ling Hsu et al.
RADIATION RESEARCH (2013)
Chronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomics
Dan A. Landau et al.
GENOME MEDICINE (2013)
Diagnostic Usefulness and Prognostic Impact of CD200 Expression in Lymphoid Malignancies and Plasma Cell Myeloma
Daisy Alapat et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2012)
Trisomy 12 and elevated GLI1 and PTCH1 transcript levels are biomarkers for Hedgehog-inhibitor responsiveness in CLL
Sarah Decker et al.
BLOOD (2012)
The Bruton tyrosine kinase inhibitor PCI-32765 thwarts chronic lymphocytic leukemia cell survival and tissue homing in vitro and in vivo
Sabine Ponader et al.
BLOOD (2012)
Stereotyped B-cell receptors in one-third of chronic lymphocytic leukemia: a molecular classification with implications for targeted therapies
Andreas Agathangelidis et al.
BLOOD (2012)
The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia
Martin F. M. de Rooij et al.
BLOOD (2012)
Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer
Alan G. Ramsay et al.
BLOOD (2012)
Hodgkin lymphoma as Richter transformation in chronic lymphocytic leukaemia: a retrospective analysis of world literature
Bruno Bockorny et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
Cancer treatment and survivorship statistics, 2012
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2012)
Interactions between bone marrow stromal microenvironment and B-chronic lymphocytic leukemia cells: Any role for Notch, Wnt and Hh signaling pathways?
Paul Faustin Seke Etet et al.
CELLULAR SIGNALLING (2012)
Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia
Lirong Pei et al.
EPIGENETICS (2012)
Bendamustine for treatment of chronic lymphocytic leukemia
Julie Elizabeth Chang et al.
EXPERT OPINION ON PHARMACOTHERAPY (2012)
Dysregulation of TNFα-induced necroptotic signaling in chronic lymphocytic leukemia: suppression of CYLD gene by LEF1
P. Liu et al.
LEUKEMIA (2012)
Chronic lymphocytic leukaemia is driven by antigen-independent cell-autonomous signalling
Marcus Duehren-von Minden et al.
NATURE (2012)
Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia
Victor Quesada et al.
NATURE GENETICS (2012)
Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia
Marta Kulis et al.
NATURE GENETICS (2012)
Merkel cell carcinoma, chronic lymphocytic leukemia and other lymphoproliferative disorders: an old bond with possible new viral ties
T. Tadmor et al.
ANNALS OF ONCOLOGY (2011)
The lymph node microenvironment promotes B-cell receptor signaling, NF-κB activation, and tumor proliferation in chronic lymphocytic leukemia
Yair Herishanu et al.
BLOOD (2011)
Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL
Susan L. Slager et al.
BLOOD (2011)
Lenalidomide as initial therapy of elderly patients with chronic lymphocytic leukemia
Xavier C. Badoux et al.
BLOOD (2011)
The genetics of Richter syndrome reveals disease heterogeneity and predicts survival after transformation
Davide Rossi et al.
BLOOD (2011)
Autoimmune cytopenia in chronic lymphocytic leukaemia: diagnosis and treatment
Kate Hodgson et al.
BRITISH JOURNAL OF HAEMATOLOGY (2011)
Nonmyeloablative Allogeneic Stem Cell Transplantation in Relapsed/Refractory Chronic Lymphocytic Leukemia Long-Term Follow-Up, Prognostic Factors, and Effect of Human Leukocyte Histocompatibility Antigen Subtype on Outcome
Issa F. Khouri et al.
CANCER (2011)
The Pax-5 Gene: A Pluripotent Regulator of B-cell Differentiation and Cancer Disease
Pierre O'Brien et al.
CANCER RESEARCH (2011)
Treating chronic lymphocytic leukemia with thalidomide and lenalidomide
Krzysztof Giannopoulos et al.
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Monophosphorylation of CD79a and CD79b ITAM Motifs Initiates a SHIP-1 Phosphatase-Mediated Inhibitory Signaling Cascade Required for B Cell Anergy
Shannon K. O'Neill et al.
IMMUNITY (2011)
Association of a MicroRNA/TP53 Feedback Circuitry With Pathogenesis and Outcome of B-Cell Chronic Lymphocytic Leukemia
Muller Fabbri et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation
Giulia Fabbri et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Intraclonal Complexity in Chronic Lymphocytic Leukemia: Fractions Enriched in Recently Born/Divided and Older/Quiescent Cells
Carlo Calissano et al.
MOLECULAR MEDICINE (2011)
Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
Xose S. Puente et al.
NATURE (2011)
SF3B1 and Other Novel Cancer Genes in Chronic Lymphocytic Leukemia
Lili Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia
Jonathan W. Friedberg et al.
BLOOD (2010)
Second malignancies in B-cell chronic lymphocytic leukaemia: possible association with human papilloma virus
Joseph M. Flynn et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
The DLEU2/miR-15a/16-1 Cluster Controls B Cell Proliferation and Its Deletion Leads to Chronic Lymphocytic Leukemia
Ulf Klein et al.
CANCER CELL (2010)
Molecular underpinning of B-cell anergy
Yuval Yarkoni et al.
IMMUNOLOGICAL REVIEWS (2010)
Ofatumumab As Single-Agent CD20 Immunotherapy in Fludarabine-Refractory Chronic Lymphocytic Leukemia
William G. Wierda et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial
M. Hallek et al.
LANCET (2010)
Monoclonal B-cell lymphocytosis (MBL): biology, natural history and clinical management
T. D. Shanafelt et al.
LEUKEMIA (2010)
A comprehensive catalogue of somatic mutations from a human cancer genome
Erin D. Pleasance et al.
NATURE (2010)
Common variants at 2q37.3, 8q24.21, 15q21.3 and 16q24.1 influence chronic lymphocytic leukemia risk
Dalemari Crowther-Swanepoel et al.
NATURE GENETICS (2010)
Elucidating the CXCL12/CXCR4 Signaling Network in Chronic Lymphocytic Leukemia through Phosphoproteomics Analysis
Morgan O'Hayre et al.
PLOS ONE (2010)
From pathogenesis to treatment of chronic lymphocytic leukaemia
Thorsten Zenz et al.
NATURE REVIEWS CANCER (2010)
B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406
Maite P. Quiroga et al.
BLOOD (2009)
Down-regulation of CXCR4 and CD62L in Chronic Lymphocytic Leukemia Cells Is Triggered by B-Cell Receptor Ligation and Associated with Progressive Disease
Amalia Vlad et al.
CANCER RESEARCH (2009)
Stereotyped B-Cell Receptor Is an Independent Risk Factor of Chronic Lymphocytic Leukemia Transformation to Richter Syndrome
Davide Rossi et al.
CLINICAL CANCER RESEARCH (2009)
Use of IGHV3-21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post-germinal center leukemogenic selection
Emanuela M. Ghia et al.
BLOOD (2008)
Lenalidomide induces complete and partial remissions in patients with relapsed and refractory chronic lymphocytic leukemia
Alessandra Ferrajoli et al.
BLOOD (2008)
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
Michael Hallek et al.
BLOOD (2008)
Rituximab in combination with high-dose methylprednisolone for the treatment of fludarabine refractory high-risk chronic lymphocytic leukemia
J. E. Castro et al.
LEUKEMIA (2008)
A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia
Maria Chiara Di Bernardo et al.
NATURE GENETICS (2008)
Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia
Andy C. Rawstron et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Antisera induced by infusions of autologous Ad-CD154-leukemia B cells identify ROR1 as an oncofetal,antigen and receptor for Wnt5a
Tetsuya Fukuda et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Quality of life in chronic lymphocytic leukemia: an international survey of 1482 patients
Tait D. Shanafelt et al.
BRITISH JOURNAL OF HAEMATOLOGY (2007)
B-cell anergy: from transgenic models to naturally occurring anergic B cells?
John C. Cambier et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Abnormal microRNA-16 locus with synteny to human 13q14 linked to CLL in NZB mice
Elizabeth S. Raveche et al.
BLOOD (2007)
Reversible anergy of sIgM-mediated signaling in the two subsets of CLL defined by VH-gene mutational status
C. Ian Mockridge et al.
BLOOD (2007)
BAFF and APRIL support chronic lymphocytic leukemia B-cell survival through activation of the canonical NF-κB pathway
Tomoyuki Endo et al.
BLOOD (2007)
Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737
Victoria Del Gaizo Moore et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia
William G. Wierda et al.
BLOOD (2007)
Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation
Ana Izcue et al.
IMMUNOLOGICAL REVIEWS (2006)
Pre-B cell proliferation and lymphoblastic leukemia/high-grade lymphoma in Eμ-miR155 transgenic mice
S Costinean et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Select high-risk genetic features predict earlier progression following chemoimmunotherapy with fludarabine and rituximab in chronic lymphocytic leukemia: Justification for risk-adapted therapy
JC Byrd et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia
GA Calin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
miR-15 and miR-16 induce apoptosis by targeting BCL2
A Cimmino et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
ZAP-70 directly enhances TgM signaling in chronic lymphocytic leukemia
LG Chen et al.
BLOOD (2005)
Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues - Facts and controversies
T Robak
DRUGS & AGING (2005)
Activation of the Wnt signaling pathway in chronic lymphocytic leukemia
DS Lu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
ZAP-70 expression and prognosis in chronic lymphocytic leukaemia
JA Orchard et al.
LANCET (2004)
ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia
LZ Rassenti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Chronic lymphocytic leukemia B cells of more than 1% of patients express virtually identical immunoglobulins
GF Widhopf et al.
BLOOD (2004)
Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia
GA Calin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression
R Bichi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Somatically mutated Ig VH3-21 genes characterize a new subset of chronic lymphocytic leukemia
G Tobin et al.
BLOOD (2002)
Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Small lymphocytic lymphoma with perifollicular, marginal zone, or interfollicular distribution
D Gupta et al.
MODERN PATHOLOGY (2000)
Environmental and heritable factors in the causation of cancer - Analyses of cohorts of twins from Sweden, Denmark, and Finland.
P Lichtenstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
